3012 ORAL Capecitabine + oxaliplatin (XELOX) vs. 5-FU/LV + oxaliplatin (FOLFOX4) as second-line treatment for patients with metastatic colorectal cancer (MCRC): Phase III trial results
暂无分享,去创建一个
Y. Bang | L. Siu | D. Cunningham | M. Rothenberg | C. Butts | M. Navarro | J. Cox | S. Gollins | R. Goel